Picture of Annexon logo

ANNX Annexon Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Annual cashflow statement for Annexon, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-130-142-134-138-207
Depreciation
Non-Cash Items18.819.816.811.713.9
Other Non-Cash Items
Changes in Working Capital3.283.74-5.86.364.23
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-106-116-121-118-186
Capital Expenditures-1.65-6.53-0.193-0.015-0.137
Purchase of Fixed Assets
Other Investing Cash Flow Items-86.66570.9-219190
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-88.258.470.7-219190
Financing Cash Flow Items0-7.99-0.555-2.26-1.62
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.79123136161109
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1936585.1-176113